Integra Lifesciences Holdings Corp
NASDAQ:IART
Wall Street
Price Targets
IART Price Targets Summary
Integra Lifesciences Holdings Corp
According to Wall Street analysts, the average 1-year price target for
IART
is 45.29 USD
with a low forecast of 37.37 USD and a high forecast of 59.85 USD.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Integra Lifesciences Holdings Corp
For the last 8 years the
compound annual growth rate for
Integra Lifesciences Holdings Corp's operating income is
9%.
The projected
CAGR
for the next 3 years is
17%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IART's stock price target?
Price Target
45.29
USD
According to Wall Street analysts, the average 1-year price target for
IART
is 45.29 USD
with a low forecast of 37.37 USD and a high forecast of 59.85 USD.
What is Integra Lifesciences Holdings Corp's Revenue forecast?
Projected CAGR
6%
For the last 8 years the
compound annual growth rate for
Integra Lifesciences Holdings Corp's revenue is
7%.
The projected
CAGR
for the next 3 years is
6%.
What is Integra Lifesciences Holdings Corp's Operating Income forecast?
Projected CAGR
17%
For the last 8 years the
compound annual growth rate for
Integra Lifesciences Holdings Corp's operating income is
9%.
The projected
CAGR
for the next 3 years is
17%.
What is Integra Lifesciences Holdings Corp's Net Income forecast?
Projected CAGR
68%
The
compound annual growth rate
of Integra Lifesciences Holdings Corp's net income for the next 3 years is
68%.
You don't have any saved screeners yet
